NEW YORK (
) hit a new 52-week high Friday as it traded at $63.07 compared with its previous 52-Week high of $63.06. Stryker is changing hands at $63.03 with 1.3 million shares traded as of 3:57 p.m. ET. Average volume has been 1.9 million shares over the past 30 days.
Stryker has a market cap of $24.2 billion and is part of the
industry. Shares are up 14.6% year to date as of the close of trading on Thursday.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. The company operates in two segments, Orthopaedic Implants and MedSurg Equipment. The company has a P/E ratio of 19.4, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 22.6.
TheStreet Ratings rates Stryker as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
52-week high stocks
or get investment ideas from our